Alterity Therapeutics Ltd at OTC Markets Life Sciences Virtual Investor Forum Transcript
Hello and welcome to Virtual Investor Conferences. My name is Richard Hantke and on the behalf of OTC Markets and Zacks Small Cap Research, we're very pleased you've joined us for the Life Sciences Investor Forum. The next presentation is from Alterity Therapeutics.
(Conference Instructions) On a final note, all of today's presentations will be recorded and available for 24/7 replay. At this point, I'm very pleased to welcome Dr. David Stamler, Chief Executive Officer of Alterity Therapeutics, which trades on the NASDAQ under the symbol ATHE; and on the ASX under the symbol ATH. Welcome, David.
Well, thank you, Rich. Good morning. Good afternoon to everyone wherever you may be. As mentioned, my name is David Stamler. I'm the Chief Executive Officer of Alterity Therapeutics, and I'm very happy to introduce our company and our strategy to you today.
These are forward-looking statements, and I encourage you to review those if you'd like further
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
